跳至主要内容
临床试验/NCT06134479
NCT06134479已完成3 期

Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.. The 2-shot Protocol.

Fundación Santiago Dexeus Font1 个研究点 分布在 1 个国家目标入组 194 人开始时间: 2023年12月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
194
试验地点
1
主要终点
Number of MII oocytes retrieved

研究概览

简要总结

This randomized was designed as non-inferiority trial aiming to compare the number of MII oocytes with 2-shot of Corifollitropin alpha (CFA) sequential administration: 150μg at stimulation day (SD) 1 and 100μg at SD 5 and 1-shot of CFA administration 150μg at SD 1 following by rFSH 200IU daily from SD 8 in women undergoing elective fertility preservation in a progestin-primed ovarian stimulation (PPOS) protocol and GnRH-agonist (GnRH-a) triggering.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Anti-Mullerian hormone (AMH) ≤3ng/ml (AMH result of up to one year will be valid)
  • Between 18 and 40 years old
  • BMI >18 and <30 kg/m2
  • Body weight > 50 kg for > 36 years
  • Able to come to the Center to comply with the procedures of the study: blood tests, appointments and drug dispensation.

排除标准

  • Medically indicated fertility preservation
  • AFC > 20
  • Polycystic ovarian syndrome (PCOS) according to the Rotterdam criteria
  • History of untreated autoimmune, endocrine or metabolic disorders
  • Contraindication for hormonal treatment
  • Recent history of severe disease requiring regular treatment (clinically significant concurrent medical condition that could compromise subject safety or interfered with the trial assessment).

研究组 & 干预措施

150μg CFA at stimulation day (SD) 1 and 100μg CFA at SD 5

Experimental

干预措施: 150μg CFA (Elonva®) at stimulation day (SD) 1 and 100μg CFA(Elonva®) at SD 5 (Drug)

150μg CFA at SD 1 following by rFSH 200IU daily from SD 8

Active Comparator

干预措施: 150μg CFA (Elonva®) at SD 1 following by rFSH (Puregon®) 200IU daily from SD 8 until the day of the trigger (Drug)

结局指标

主要结局

Number of MII oocytes retrieved

时间窗: Trough study completion, an average of 10-20 days.

Number of MII oocytes retrieved

次要结局

  • Total number of oocytes retrieved(Trough study completion, an average of 10-20 days.)
  • FSH(Up to oocyte pickup, an average of 10-20 days.)
  • LH(Up to oocyte pickup, an average of 10-20 days.)
  • PROGESTERONE(Up to oocyte pickup, an average of 10-20 days.)
  • Estradiol(Up to oocyte pickup, an average of 10-20 days.)
  • OHSS(Until 15 days after day of oocyte pick-up)
  • FertiQoL(from stimulation day 1 until the day of oocyte pick-up,10-20 days after the beggining of the stimulation.)
  • Length of stimulation(up to 18 days)
  • Adverse events(up to 20days)

研究者

发起方
Fundación Santiago Dexeus Font
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验